抑制SUMOylation增强了葡萄糖皮质体受体的作用,以计划急性淋巴细胞白血病细胞的生长停止
Emma Valima1, Vera Varis1, Kseniia Bureiko1
1Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland.
Oncogene
|February 14, 2025
概括
向SUMOylation增强了B细胞急性淋巴细胞白血病 (B-ALL) 的葡萄糖皮质体治疗. 抑制SUMOylation会增加葡萄糖皮质体受体的结合,抑制细胞生长基因,并提高B-ALL细胞和患者样本的治疗效率.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 葡萄糖皮质醇对于治疗B细胞急性淋巴细胞白血病 (B-ALL) 是必不可少的.
- 葡萄糖皮质体受体 (GR) 调解葡萄糖皮质体的作用,其功能由SUMOylation调节.
- 在血液性恶性瘤中SUMOylation的治疗潜力表明它在B-ALL.中的相关性.
研究的目的:
- 为了研究GR和B-ALL中的SUMOylation之间的相互作用.
- 确定抑制SUMOylation对GR功能和B-ALL细胞行为的影响.
主要方法:
- 在使用SUMOylation抑制剂 (ML-792) 诱导NALM6 B-ALL细胞的低SUMOylation.
- 进行了GR和SUMO染色体结合和染色体可访问性的全基因组分析.
- 进行了转录组和蛋白质组分析,以评估基因表达和蛋白质网络.
主要成果:
- 低SUMOylation增加了GR染色体占用率,并改变了染色体的可访问性.
- 由hypoSUMOylation诱导的GR结合位主要抑制了参与细胞循环和DNA复制的基因.
- 低SUMOylation增强了葡萄糖皮质醇诱导的细胞循环停止和B-ALL细胞的生长抑制.
- 蛋白质组分析显示,SUMO2/3是染色质结合的GR网络的组成部分,影响其稳定性.
结论:
- 向SUMOylation可能会提高B-ALL.的葡萄糖皮质激素敏感性.
- 与葡萄糖皮质类药物和SUMOylation抑制剂的联合治疗显示出有希望的结果,得到了ex vivo患者样本数据的支持.
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Eukaryotic Transcription Inhibitors
9.8K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
GPCR Desensitization
5.7K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.7K
GPCRs Regulate Adenylyl Cylase Activity
5.1K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.1K


